Does ABEMACICLIB Cause Therapy cessation? 237 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 237 reports of Therapy cessation have been filed in association with ABEMACICLIB (Verzenio). This represents 1.5% of all adverse event reports for ABEMACICLIB.
237
Reports of Therapy cessation with ABEMACICLIB
1.5%
of all ABEMACICLIB reports
0
Deaths
46
Hospitalizations
How Dangerous Is Therapy cessation From ABEMACICLIB?
Of the 237 reports, 46 (19.4%) required hospitalization, and 1 (0.4%) were considered life-threatening.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ABEMACICLIB. However, 237 reports have been filed with the FAERS database.
What Other Side Effects Does ABEMACICLIB Cause?
Diarrhoea (4,988)
Fatigue (1,878)
Nausea (1,682)
Vomiting (943)
Malignant neoplasm progression (890)
Decreased appetite (744)
Death (696)
Asthenia (678)
Drug ineffective (668)
White blood cell count decreased (566)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which ABEMACICLIB Alternatives Have Lower Therapy cessation Risk?
ABEMACICLIB vs ABILIFY
ABEMACICLIB vs ABIRATERONE
ABEMACICLIB vs ABIRATERONE\ABIRATERONE
ABEMACICLIB vs ABOBOTULINUMTOXINA
ABEMACICLIB vs ABRAXANE